Delivery Order SPE2DX15D2205-SPE2DX24F76EA

Award Date 1/5/24
Potential Completion Date 1/8/24
Potential Value $4.3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $5,660.64 contract is for the supply of FOCALIN XR 10 MG CAPSULE 100S, a prescription medication, with a completion date of March 8, 2024. This delivery order is part of a larger, single award indefinite delivery contract (IDC) between DLA and...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide FOCALIN XR 15 mg capsules. The contract has a completion date of February 28, 2024 and a potential value of $2,782.98. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will deliver the pharmaceutical products from its corporate office in Conshohocken,...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,580,158 units of Focalin XR 30 mg capsules. The potential value of this contract is $8,796.70, with a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations for this award. This contract is associated with a larger...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a wholly-owned subsidiary of Amerisourcebergen Corporation. The $8,507.77 contract is for the delivery of Focalin XR 30 mg capsules to support military treatment programs and facilities. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corporation, with a potential value of $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $11,494.43 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the supply of Focalin XR 10 mg capsules and has a completion date of February 6, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, holds an indefinite delivery contract with DLA Troop Support Medical to provide a comprehensive...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $3,522.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 100 units of Focalin XR 15 mg capsules, with a completion date of February 13, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, primarily...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,884.93 to Amerisourcebergen Drug Corp, a global pharmaceutical distribution company. The contract is for the supply of 100 units of Focalin XR 10 mg capsules, with a completion date of January 30, 2024. Amerisourcebergen Drug Corp has a larger indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of up to $999,999,999.00 and a performance...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,710,913 units of FOCALIN XR 15 MG CAPSULE 100S. The contract has a potential value of $2,806.92 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside program. Additionally, Amerisourcebergen Drug Corp holds an...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $4,089.48 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of FOCALIN XR 20 MG CAPSULE 100S. The contract, which has a completion date of February 16, 2024, is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and this delivery order falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $11,507.85 to Amerisourcebergen Drug Corp, a subsidiary of the for-profit pharmaceutical company Amerisourcebergen Corporation. This contract is for the delivery of Focalin XR 15 mg capsules to support military treatment facilities and programs. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to...
  • SPE2DX15D2205
    Indefinite Delivery Contract
  • SPE2DX15D2205-SPE2DX24F76EA
    Delivery Order

The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $4,321.37 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of FOCALIN XR 10 mg capsules. This delivery order is part of a larger indefinite delivery contract between Amerisourcebergen Drug Corp and DLA Troop Support Medical to provide pharmaceuticals and medical supplies to support military treatment programs and facilities. The contract has a period of performance through January 8, 2024 and does not include a set-aside designation.

Generated 4/5/24, 9:20 AM